Time to diagnosis in esophageal cancer: a cohort study

References

• Pennathur A, Gibson MK, Jobe BA, et al. Oesophageal carcinoma. Lancet. 2013;381:400–412.
   PubMed Web of Science ®Google Scholar
• De Angelis R, Sant M, Coleman MP, et al. Cancer survival in Europe 1999–2007 by country and age: results of EUROCARE-5 a population-based study. Lancet Oncol. 2014;15:23–34.
   PubMed Web of Science ®Google Scholar
• Neal RD. Do diagnostic delays in cancer matter? Br J Cancer. 2009;101(Suppl 2):S9–S12.
   PubMed Web of Science ®Google Scholar
• Richards MA, Westcombe AM, Love SB, et al. Influence of delay on survival in patients with breast cancer: a systematic review. Lancet. 1999;353:1119–1126.
   PubMed Web of Science ®Google Scholar
• Emery J, Shaw K, Williams B, et al. The role of primary care in early detection and follow-up of cancer. Nat Rev Clin Oncol. 2014;11:38–48.
   PubMed Web of Science ®Google Scholar
• Keeble S, Abel GA, Saunders CL, et al. Variation in promptness of presentation among 10297 patients subsequently diagnosed with one of 18 cancers: evidence from a National Audit of Cancer Diagnosis in Primary Care. Int J Cancer. 2014;135:1220–1228.
   PubMed Web of Science ®Google Scholar
• Forbes LJ, Warburton F, Richards MA, et al. Risk factors for delay in symptomatic presentation: a survey of cancer patients. Br J Cancer. 2014;111:581–588.
   PubMed Web of Science ®Google Scholar
• Walter FM, Rubin G, Bankhead C, et al. Symptoms and other factors associated with time to diagnosis and stage of lung cancer: a prospective cohort study. Br J Cancer. 2015;112(Suppl 1):S6–S13.
   PubMed Web of Science ®Google Scholar
• Lordick F, Mariette C, Haustermans K, et al. Oesophageal cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2016;27(Suppl 5):v50–v57.
   Web of Science ®Google Scholar
• Neal RD, Tharmanathan P, France B, et al. Is increased time to diagnosis and treatment in symptomatic cancer associated with poorer outcomes? Systematic review. Br J Cancer. 2015;112(Suppl 1):S92–S107.
   PubMed Web of Science ®Google Scholar
• Hansen RP, Vedsted P, Sokolowski I, et al. Time intervals from first symptom to treatment of cancer: a cohort study of 2,212 newly diagnosed cancer patients. BMC Health Serv Res. 2011;11:284.
   PubMed Web of Science ®Google Scholar
• Iacobucci G. New campaign to raise awareness of oesophago-gastric cancer may lead to over-investigation, expert warns. BMJ. 2015;350:h450.
   PubMed Web of Science ®Google Scholar
• Weller D, Vedsted P, Rubin G, et al. The Aarhus statement: improving design and reporting of studies on early cancer diagnosis. Br J Cancer. 2012;106:1262–1267.
   PubMed Web of Science ®Google Scholar
• Edge SB, Byrd DR, Compton CC, et al. AJCC cancer staging manual. 7th ed. New York (NY): Springer; 2010.
   Google Scholar
• Ruol A, Castoro C, Portale G, et al. Trends in management and prognosis for esophageal cancer surgery: twenty-five years of experience at a single institution. Arch Surg. 2009;144:247–254.
   PubMedGoogle Scholar
• Punt CJ, Buyse M, Kohne CH, et al. Endpoints in adjuvant treatment trials: a systematic review of the literature in colon cancer and proposed definitions for future trials. J Natl Cancer Inst. 2007;99:998–1003.
   PubMed Web of Science ®Google Scholar
• Redaniel MT, Martin RM, Ridd MJ, et al. Diagnostic intervals and its association with breast, prostate, lung and colorectal cancer survival in England: historical cohort study using the clinical practice research datalink. PLoS One. 2015;10:e0126608.
   PubMed Web of Science ®Google Scholar
• Grotenhuis BA, van Hagen P, Wijnhoven BP, et al. Delay in diagnostic workup and treatment of esophageal cancer. J Gastrointest Surg. 2010;14:476–483.
   PubMed Web of Science ®Google Scholar
• Martin IG, Young S, Sue-Ling H, et al. Delays in the diagnosis of oesophagogastric cancer: a consecutive case series. BMJ. 1997;314:467–470.
   PubMed Web of Science ®Google Scholar
• Sharpe D, Williams RN, Ubhi SS, et al. The “two-week wait” referral pathway allows prompt treatment but does not improve outcome for patients with oesophago-gastric cancer”. Eur J Surg Oncol. 2010;36:977–981.
   PubMed Web of Science ®Google Scholar
• Wang J, Liu F, Gao H, et al. The symptom-to-treatment delay and stage at the time of treatment in cancer of esophagus. Jpn J Clin Oncol. 2008;38:87–91.
   PubMed Web of Science ®Google Scholar
• Macdonald S, Macleod U, Campbell NC, et al. Systematic review of factors influencing patient and practitioner delay in diagnosis of upper gastrointestinal cancer. Br J Cancer. 2006;94:1272–1280.
   PubMed Web of Science ®Google Scholar
• Zambon P, Talamini R, Vecchia CL, et al. Smoking, type of alcoholic beverage and squamous-cell esophageal cancer in northern Italy. Int J Cancer. 2000;86:144–149.
   PubMed Web of Science ®Google Scholar
• Negri E, La Vecchia C, Franceschi S, et al. Attributable risks for oesophageal cancer in northern Italy. Eur J Cancer. 1992;28A:1167–1171.
   PubMed Web of Science ®Google Scholar
• Pedersen AF, Olesen F, Hansen RP, et al. Social support, gender and patient delay. Br J Cancer. 2011;104:1249–1255.
   PubMed Web of Science ®Google Scholar
• Gandon A, Gronnier C, Renaud F, et al. Esophageal adenocarcinoma: impact. of a large hiatal hernia on outcomes after surgery. Ann Surg. 2016;264:862–870.
   PubMed Web of Science ®Google Scholar
• Roman S, Kahrilas PJ. The diagnosis and management of hiatus hernia. BMJ. 2014;349:g6154.
   PubMed Web of Science ®Google Scholar
• Fernandez E, Porta M, Malats N, et al. Symptom-to-diagnosis interval and survival in cancers of the digestive tract. Dig Dis Sci. 2002;47:2434–2440.
   PubMed Web of Science ®Google Scholar
• Tokuda Y, Chinen K, Obara H, et al. Intervals between symptom onset and clinical presentation in cancer patients. Intern Med. 2009;48:899–905.
   PubMed Web of Science ®Google Scholar
• Allemani C, Matsuda T, Di Carlo V, et al. Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries. Lancet. 2018;391:1023–1075.
   PubMed Web of Science ®Google Scholar
• Altman DG, Royston P. The cost of dichotomising continuous variables. BMJ. 2006;332:1080.
   PubMed Web of Science ®Google Scholar